- For intravenous use only and is indicated for the short-term treatment of patients with cardiac decompensation due to depressed heart contractility
Features:
- Synthetic catecholamine used for its positive inotropic effects on the heart
- It is a 1000mg dose in 250mL of 5% Dextrose, resulting in a concentration of 4000mcg/mL
- For intravenous use only
- Indicated for the short-term treatment of patients with cardiac decompensation due to depressed heart contractility
- Administered as a continuous intravenous infusion using a calibrated electronic infusion device
- Infusion rates vary, typically from 2-20mcg/kg/min
- Container system may not be suitable for pediatric patients under 30kg
- Continuous monitoring of vital signs and cardiac function is recommended during administration
